Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 61.26x is in line with its estimated 1-year average of 56.79x, around the middle of its estimated 1-year range (7.46x–86.81x).
As of 2026-10-06T19:45:42.237Z.
Calculation as of: 2026-10-06T19:45:42.237Z.
Quote observation: 2026-10-06T19:44:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 237c69f2886ce95022375c2c4ca3b4be9bdf1b13d47079a179ac8fcd7ebd926e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
61.26x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.37x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+1301.83%
vs the sector median at left
Allarity Therapeutics, Inc.
Market Cap
$15.83M
EV/Sales Ratio
61.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.78M
EV/Sales Ratio
N/A
TTM Avg
492.25x
3Y Avg
202.04x
5Y Avg
285.29x
Market Cap
$15.54M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.24M
EV/Sales Ratio
43.66x
TTM Avg
46.98x
3Y Avg
46.98x
5Y Avg
36.15x
Market Cap
$16.57M
EV/Sales Ratio
5.81x
TTM Avg
10.55x
3Y Avg
12.56x
5Y Avg
17.17x
Market Cap
$16.67M
EV/Sales Ratio
1.04x
TTM Avg
10.15x
3Y Avg
24.96x
5Y Avg
21.29x
Market Cap
$16.74M
EV/Sales Ratio
0.72x
TTM Avg
1.08x
3Y Avg
179.64x
5Y Avg
2065.58x
Market Cap
$16.75M
EV/Sales Ratio
0.65x
TTM Avg
0.67x
3Y Avg
1.03x
5Y Avg
10.93x
Market Cap
$14.82M
EV/Sales Ratio
1.20x
TTM Avg
1.84x
3Y Avg
1.65x
5Y Avg
2.08x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.83M | 61.26x | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 492.25x | 202.04x | 285.29x |
| Jin Medical International Ltd. (ZJYL)vs › | $15.54M | N/A | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | 43.66x | 46.98x | 46.98x | 36.15x |
| Dyadic International, Inc. (DYAI)vs › | $16.57M | 5.81x | 10.55x | 12.56x | 17.17x |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.67M | 1.04x | 10.15x | 24.96x | 21.29x |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | 0.72x | 1.08x | 179.64x | 2065.58x |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | 0.65x | 0.67x | 1.03x | 10.93x |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.82M | 1.20x | 1.84x | 1.65x | 2.08x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.88M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 61.49x |
| 2026-10-02 | 63.34x |
| 2026-10-01 | 63.34x |
| 2026-09-30 | 63.80x |
| 2026-09-29 | 59.88x |
| 2026-09-28 | 60.03x |
| 2026-09-25 | 62.88x |
| 2026-09-24 | 65.64x |
| 2026-09-23 | 63.34x |
| 2026-09-22 | 66.56x |
| 2026-09-21 | 69.33x |
| 2026-09-18 | 71.18x |
| 2026-09-17 | 68.87x |
| 2026-09-16 | 68.87x |
| 2026-09-15 | 66.56x |
| 2026-09-14 | 69.33x |
| 2026-09-11 | 71.64x |
| 2026-09-10 | 73.02x |
| 2026-09-09 | 73.48x |
| 2026-09-08 | 73.02x |
| 2026-09-04 | 80.86x |
| 2026-09-03 | 81.32x |
| 2026-09-02 | 80.40x |
| 2026-09-01 | 80.86x |
| 2026-08-31 | 80.40x |
| 2026-08-28 | 80.40x |
| 2026-08-27 | 79.02x |
| 2026-08-26 | 77.17x |
| 2026-08-25 | 76.71x |
| 2026-08-24 | 79.48x |
| 2026-08-21 | 80.86x |
| 2026-08-20 | 81.32x |
| 2026-08-19 | 81.32x |
| 2026-08-18 | 77.63x |
| 2026-08-17 | 77.17x |
| 2026-08-14 | 68.29x |
| 2026-08-13 | 67.83x |
| 2026-08-12 | 69.68x |
| 2026-08-11 | 71.07x |
| 2026-08-10 | 70.14x |
| 2026-08-07 | 69.22x |
| 2026-08-06 | 69.68x |
| 2026-08-05 | 66.44x |
| 2026-08-04 | 65.52x |
| 2026-08-03 | 63.66x |
| 2026-07-31 | 60.89x |
| 2026-07-30 | 61.81x |
| 2026-07-29 | 58.57x |
| 2026-07-28 | 59.50x |
| 2026-07-27 | 61.81x |
| 2026-07-24 | 59.96x |
| 2026-07-23 | 61.35x |
| 2026-07-22 | 64.13x |
| 2026-07-21 | 61.35x |
| 2026-07-20 | 59.04x |
| 2026-07-17 | 59.96x |
| 2026-07-16 | 59.04x |
| 2026-07-15 | 59.50x |
| 2026-07-14 | 58.57x |
| 2026-07-13 | 57.18x |
| 2026-07-10 | 59.04x |
| 2026-07-09 | 60.42x |
| 2026-07-08 | 58.57x |
| 2026-07-07 | 57.18x |
| 2026-07-06 | 60.42x |
| 2026-07-02 | 65.52x |
| 2026-07-01 | 66.44x |
| 2026-06-30 | 64.59x |
| 2026-06-29 | 65.05x |
| 2026-06-26 | 65.05x |
| 2026-06-25 | 63.66x |
| 2026-06-24 | 65.05x |
| 2026-06-23 | 65.98x |
| 2026-06-22 | 67.83x |
| 2026-06-18 | 71.07x |
| 2026-06-17 | 66.90x |
| 2026-06-16 | 71.07x |
| 2026-06-15 | 73.38x |
| 2026-06-12 | 71.07x |
| 2026-06-11 | 76.62x |
| 2026-06-10 | 73.85x |
| 2026-06-09 | 79.40x |
| 2026-06-08 | 78.01x |
| 2026-06-05 | 79.40x |
| 2026-06-04 | 83.57x |
| 2026-06-03 | 78.01x |
| 2026-06-02 | 83.10x |
| 2026-06-01 | 84.49x |
| 2026-05-29 | 80.79x |
| 2026-05-28 | 82.18x |
| 2026-05-27 | 84.96x |
| 2026-05-26 | 83.10x |
| 2026-05-22 | 86.81x |
| 2026-05-21 | 81.72x |
| 2026-05-20 | 73.85x |
| 2026-05-19 | 73.85x |
| 2026-05-18 | 71.07x |
| 2026-05-15 | 19.14x |
| 2026-05-14 | 26.33x |
| 2026-05-13 | 27.68x |
| 2026-05-12 | 26.78x |
| 2026-05-11 | 33.97x |
| 2026-05-08 | 28.13x |
| 2026-05-07 | 25.88x |
| 2026-05-06 | 24.98x |
| 2026-05-05 | 21.39x |
| 2026-05-04 | 14.65x |
| 2026-05-01 | 16.89x |
| 2026-04-30 | 19.14x |
| 2026-04-29 | 20.49x |
| 2026-04-28 | 20.04x |
| 2026-04-27 | 20.04x |
| 2026-04-24 | 18.69x |
| 2026-04-23 | 21.39x |
| 2026-04-22 | 21.39x |
| 2026-04-21 | 20.49x |
| 2026-04-20 | 14.65x |
| 2026-04-17 | 13.75x |
| 2026-04-16 | 14.20x |
| 2026-04-15 | 14.65x |
| 2026-04-14 | 11.95x |
| 2026-04-13 | 11.95x |
| 2026-04-10 | 15.54x |
| 2026-04-09 | 10.15x |
| 2026-04-08 | 10.60x |
| 2026-04-07 | 10.60x |
| 2026-04-06 | 11.50x |
| 2026-04-02 | 10.60x |
| 2026-04-01 | 9.25x |
| 2026-03-31 | 7.46x |
